13th Award: Effect of Multikinase Inhibitors on Caspase-Independent Cell Death and DNA Damage in HER2-Overexpressing Breast Cancer Cells

A combination of two drugs, trastuzumab and dasatinib, improve the treatment response by 30% in breast cancers, those in which tumour cells show an overexposure to the HER2 protein. This is the discovery of four scientists from Cancer Research Centre (CIC-IBMCC), part of the University of Salamanca and CSIC, who were awarded the 13th Esteve… 2013